Home > Balance Sheet > BLISS GVS PHARMA

BLISS GVS PHARMA
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Contingent Liabilities ₹12 Cr₹23 Cr₹30 Cr₹14 Cr₹2.09 Cr

What is the latest Contingent Liabilities ratio of BLISS GVS PHARMA ?

The latest Contingent Liabilities ratio of BLISS GVS PHARMA is ₹12 Cr based on Mar2023 Consolidated results.
Year Contingent Liabilities
Mar2023₹12 Cr
Mar2022₹23 Cr
Mar2021₹30 Cr
Mar2020₹14 Cr
Mar2019₹2.09 Cr

How is Contingent Liabilities of BLISS GVS PHARMA Trending?

Years Contingent Liabilities % Change
Mar2023 ₹12 Cr
-48.95
Mar2022 ₹23 Cr
-25.09
Mar2021 ₹30 Cr
111.47
Mar2020 ₹14 Cr
587.06
Mar2019 ₹2.09 Cr -

Compare Contingent Liabilities of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,247.0 Cr -2.9% 2.7% 68.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-2.9%

2.7%

68.9%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses